Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von PR-Newswire bereitgestellt.
NEW YORK, Dec. 21, 2024 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ASP Isotopes Inc. (NASDAQ: ASPI) between October 30, 2024 and November 26, 2024, both dates inclusive (the "Class Period"), of the important February 3, 2025 lead plaintiff deadline.
So what: If you purchased ASP Isotopes securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, Dec. 20, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against ASP Isotopes Inc. ("ASPI" or the "Company") (NASDAQ: ASPI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
LOS ANGELES, Dec. 20, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against ASP Isotopes Inc. ("ASP Isotopes" or the "Company") (NASDAQ: ASPI).
Class Period: October 30, 2024 – November 26, 2024Lead Plaintiff Deadline: February 3, 2025
If you wish to serve as lead plaintiff of the ASP Isotopes lawsuit, you can submit your contact information at www.glancylaw.com/cases/ASP-Isotopes-Inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.
NEW YORK, Dec. 20, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ASP Isotopes Inc. ("ASP Isotopes Inc." or the "Company") (NASDAQ: ASPI) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ASP Isotopes Inc. investors who were adversely affected by alleged securities fraud between October 30, 2024 and November 26, 2024. Follow the link below to get more information and be contacted by a member of our team:
NEW YORK, Dec. 17, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ: ASPI) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ASP Isotopes securities between October 30, 2024 and November 26, 2024, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/ASPI.
NEW YORK, Dec. 17, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ASP Isotopes Inc. ("ASP Isotopes Inc." or the "Company") (NASDAQ: ASPI) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ASP Isotopes Inc. investors who were adversely affected by alleged securities fraud between October 30, 2024 and November 26, 2024. Follow the link below to get more information and be contacted by a member of our team:
LOS ANGELES, Dec. 16, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against ASP Isotopes Inc. ("ASP Isotopes" or the "Company") (NASDAQ: ASPI).
Class Period: October 30, 2024 – November 26, 2024Lead Plaintiff Deadline: February 3, 2025
If you are a shareholder who suffered a loss, click here to participate.
NEW YORK, Dec. 16, 2024 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ASP Isotopes Inc. (NASDAQ: ASPI) between October 30, 2024 and November 26, 2024, both dates inclusive (the "Class Period"), of the important February 3, 2025 lead plaintiff deadline.
So what: If you purchased ASP Isotopes securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, Dec. 16, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ASP Isotopes Inc. (NASDAQ: ASPI).
Shareholders who purchased shares of ASPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CONTACT US HERE:
NEW YORK, Dec. 13, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ASP Isotopes Inc. ("ASP Isotopes Inc." or the "Company") (NASDAQ: ASPI) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ASP Isotopes Inc. investors who were adversely affected by alleged securities fraud between October 30, 2024 and November 26, 2024. Follow the link below to get more information and be contacted by a member of our team: